ICICI Prudential Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$737K Hold
3,877
0.08% 144
2026
Q1
$655K Hold
3,877
0.08% 139
2025
Q4
$654K Hold
3,877
0.08% 142
2025
Q3
$560K Hold
3,877
0.06% 143
2025
Q2
$490K Hold
3,877
0.06% 139
2025
Q1
$496K Hold
3,877
0.06% 134
2024
Q4
$513K Hold
3,877
0.06% 137
2024
Q3
$564K Hold
3,877
0.06% 128
2024
Q2
$532K Hold
3,877
0.06% 122
2024
Q1
$532K Buy
+3,877
New +$529K 0.06% 125
2023
Q2
Sell
-5,759
Closed -$744K 162
2023
Q1
$744K Buy
+5,759
New +$754K 0.11% 84
2022
Q3
Sell
-7,597
Closed -$896K 155
2022
Q2
$896K Hold
7,597
0.16% 73
2022
Q1
$995K Buy
+7,597
New +$990K 0.13% 71

Other funds holding IBB

ICICI Prudential Asset Management's IBB Position: Q2 2026 in Review

ICICI Prudential Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 3,877 shares worth $737K. The position accounts for 0.08% of the portfolio, ranked #144.

ICICI Prudential Asset Management first reported a position in IBB in Q1 2022 and has held it in 13 quarters since. The position peaked at $995K in Q1 2022. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • ICICI Prudential Asset Management held 3,877 shares of iShares Biotechnology ETF worth $737K as of Q2 2026.
  • ICICI Prudential Asset Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.08% of ICICI Prudential Asset Management's portfolio in Q2 2026, its #144 holding.
  • ICICI Prudential Asset Management first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 13 quarters since.
  • ICICI Prudential Asset Management's iShares Biotechnology ETF position peaked at $995K in Q1 2022.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on ICICI Prudential Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.